Low-value levels: Ammonia testing does not improve the outcomes of overt hepatic encephalopathy

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hepatic encephalopathy is a clinical diagnosis. However, many clinicians measure ammonia levels in hospitalized patients presenting with hepatic encephalopathy. In this editorial, we review the results of an important study by Haj and Rockey. The authors examined the management decisions effected affected by and outcomes associated with (i) ordering an ammonia level and (ii) knowing the ammonia level. They found that ammonia level determination did not impact affect clinical decision-making or patient outcomes. These persuasive data demonstrate the limited clinical utility of ammonia levels and highlight the need for testing stewardship to dissuade unnecessary use through educational efforts and decision supports.

Cite

CITATION STYLE

APA

Tapper, E. B., & Rahimi, R. S. (2020). Low-value levels: Ammonia testing does not improve the outcomes of overt hepatic encephalopathy. American Journal of Gastroenterology. Wolters Kluwer Health. https://doi.org/10.14309/ajg.0000000000000454

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free